BACKGROUND: Adherence to drug treatment and health-related quality of life (HRQL) are two distinct concepts. Generally one would expect a positive relationship between the two. OBJECTIVES: The purpose of this study was to assess the relationship between adherence and HRQL. METHODS: HRQL was measured using the physical and mental summary measures of the RAND-12 (PHC-12, MHC-12), the SF-12 (PCS-12, MCS-12), HUI-2 and HUI-3. Adherence was assessed using Morisky's instrument. Three longitudinal datasets were used. One dataset included 100 hypertensive patients. Another dataset covered 199 high risk community-dwelling individuals. The third dataset consisted of 365 elderly patients. Spearman's correlation coefficients were used to assess association. Subgroup analyses by type of medication and inter-temporal analyses were also performed. RESULTS: Correlation between adherence and PHC-12 ranged from 0.08 (p = 0.26) to 0.22 (p < 0.01). Correlations between adherence and MHC-12 ranged from 0.11 (p = 0.11) to 0.15 (p < 0.01). Similar results were observed using HUI-2, HUI-3, and SF-12 as well as by type of medication and in the lagged analyses. CONCLUSIONS: Correlations between HRQL and adherence were positive but typically weak or negligible in magnitude.
BACKGROUND: Adherence to drug treatment and health-related quality of life (HRQL) are two distinct concepts. Generally one would expect a positive relationship between the two. OBJECTIVES: The purpose of this study was to assess the relationship between adherence and HRQL. METHODS: HRQL was measured using the physical and mental summary measures of the RAND-12 (PHC-12, MHC-12), the SF-12 (PCS-12, MCS-12), HUI-2 and HUI-3. Adherence was assessed using Morisky's instrument. Three longitudinal datasets were used. One dataset included 100 hypertensivepatients. Another dataset covered 199 high risk community-dwelling individuals. The third dataset consisted of 365 elderly patients. Spearman's correlation coefficients were used to assess association. Subgroup analyses by type of medication and inter-temporal analyses were also performed. RESULTS: Correlation between adherence and PHC-12 ranged from 0.08 (p = 0.26) to 0.22 (p < 0.01). Correlations between adherence and MHC-12 ranged from 0.11 (p = 0.11) to 0.15 (p < 0.01). Similar results were observed using HUI-2, HUI-3, and SF-12 as well as by type of medication and in the lagged analyses. CONCLUSIONS: Correlations between HRQL and adherence were positive but typically weak or negligible in magnitude.
Authors: W M Hopman; T Towheed; T Anastassiades; A Tenenhouse; S Poliquin; C Berger; L Joseph; J P Brown; T M Murray; J D Adachi; D A Hanley; E Papadimitropoulos Journal: CMAJ Date: 2000-08-08 Impact factor: 8.262
Authors: Fahad Saleem; Mohamed Azmi Hassali; Asrul Akmal Shafie; George A Awad; Muhammad Atif; Noman ul Haq; Hisham Aljadhey; Maryam Farooqui Journal: BMC Public Health Date: 2012-04-30 Impact factor: 3.295
Authors: Elizabeth Winter Holt; Paul Muntner; Cara Jean Joyce; Larry Webber; Marie A Krousel-Wood Journal: Age Ageing Date: 2010-05-31 Impact factor: 10.668
Authors: Jia-Rong Wu; Debra K Moser; Marla J De Jong; Mary Kay Rayens; Misook L Chung; Barbara Riegel; Terry A Lennie Journal: Am Heart J Date: 2008-12-24 Impact factor: 4.749
Authors: Suliman A AlGhurair; Christine A Hughes; Scot H Simpson; Lisa M Guirguis Journal: J Clin Hypertens (Greenwich) Date: 2012-08-20 Impact factor: 3.738